Podcast: The race to develop innovative products and supply chain solutions 

In the final episode of the pharmaphorum podcast series, Sandra Anderson, SVP of international commercialization at Cencora, and Chris Williams, SVP and international managing director of Alloga Europe and ICS, discuss the considerations and challenges involved in launching a biopharmaceutical product in Europe. They emphasize the importance of a thorough launch plan that takes into account different market access requirements across geographies. Understanding the differences in HTA processes between countries like the UK, Germany, France, and Sweden is crucial to prevent delays. The race to develop innovative products poses practical challenges in the supply chain. Early engagement and a logistics perspective are key for a successful product launch. Cencora offers multi-country solutions to support biopharma companies in bringing their products to market efficiently by addressing complexities throughout the process.